E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Impact in
- Oncology 136
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w47209465 →Countries where authors are citing E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
This map shows the geographic impact of E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. more than expected).
Fields of papers citing E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
This network shows the impact of E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas..
About E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
This paper, published in 1995, received 668 indexed citations . Written by Jeremy R. Graff, James G. Herman, Rena G. Lapidus, Hemi Chopra, Rou Xu, David F. Jarrard, William B. Isaacs, Paula M. Pitha, Nancy E. Davidson and Stephen B. Baylin covering the research area of Molecular Biology. It is primarily cited by scholars working on Molecular Biology (577 citations), Oncology (136 citations), Cancer Research (102 citations), Pulmonary and Respiratory Medicine (89 citations) and Genetics (81 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w47209465.